[Click e-Stock] "DongKook Pharmaceutical Accelerates Cosmetics Exports and New Drug Platform Growth... Target Price Raised"
On March 30, LS Securities maintained its "Buy" investment rating for DongKook Pharmaceutical, raising its target share price from KRW 25,000 to KRW 30,000. The company cited a clear improvement in performance, driven by the expansion of cosmetics exports and its advanced drug delivery system (DDS) technology.
On the same day, Hong Sik Jeong, a researcher at LS Securities, stated, "We have raised our operating profit estimates for 2026 and 2027 to reflect improved performance resulting from the expansion of cosmetics exports."
He first analyzed that DongKook Pharmaceutical's cosmetics sales conditions in the first quarter of this year are highly favorable. The company expects a dramatic increase in cosmetics export revenue, especially to the United States and Japan, from around KRW 30 billion last year to over KRW 100 billion this year.
According to Jeong, DongKook Pharmaceutical's cosmetics sales are expected to rise from KRW 154.9 billion in 2023 to KRW 181.5 billion in 2024, KRW 222.7 billion in 2025, and KRW 293 billion this year, representing a 31.6% year-over-year increase and maintaining a strong growth trend. The company is receiving positive feedback overseas for its competitive products, such as wrinkle improvement and whitening solutions, which utilize the skin regeneration ingredient TECA (the active ingredient in Madecassol).
Interest in the microsphere (sustained-release long-acting injectable) platform, a medium- to long-term growth engine, is also expected to grow. DongKook Pharmaceutical possesses drug delivery system technology that allows drugs to be released slowly within the body.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Jeong added, "The company has already proven its mass-production competitiveness through products such as LHRH depot. Last month, it demonstrated its technological prowess again by successfully completing phase 3 clinical trials for the three-month formulation. Preclinical studies for an obesity treatment utilizing this platform are also underway."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.